文献速递焦虑、强迫与应激相关障碍

PTSD心理治疗结局可由情绪反应与调节时的脑激活预测

PTSD Psychotherapy Outcome Predicted by Brain Activation During Emotional Reactivity and Regulation.
PubMed 文献 · Am J Psychiatry · 2017-07-18

该研究考察PTSD患者在接受延长暴露治疗前,情绪反应与调节相关脑功能能否预测疗效。结果显示,情绪反应时背侧前额叶激活更强、左侧杏仁核激活更弱,以及右侧背外侧前额叶单脉冲TMS对左侧杏仁核抑制更好、情绪冲突调节时腹内侧前额叶/腹侧纹状体激活更强的个体,症状改善更明显;重评相关激活未显著调节疗效。

要点

  • 情绪反应时背侧前额叶激活更强与延长暴露症状改善相关
  • 情绪反应时左侧杏仁核激活更弱与延长暴露症状改善相关
  • 右侧背外侧前额叶TMS对左侧杏仁核抑制更好与疗效相关

核心结论

  • PTSD患者从延长暴露治疗中获益的能力受前额叶资源在浅层加工威胁和适应性缓解情绪干扰时自发参与程度的影响,而非刻意减少负性情绪时。

研究设计与样本

  • PTSD个体在完成三项评估情绪反应与调节的任务时接受功能磁共振成像(fMRI),随后随机分配至立即延长暴露治疗组(N=36)或等待名单组(N=30)。
  • 延长暴露组中随机子集(N=17)在接受单脉冲经颅磁刺激(TMS)同时进行fMRI,以检验预测性激活模式是否反映环路内因果影响。
  • 采用意向性治疗原则的线性混合效应模型检验基线脑功能如何调节治疗对PTSD症状的效果。

主要发现

  • 基线时,与等待名单条件相比,治疗相关症状减幅更大的个体在情绪反应期间表现出更大的背侧前额叶激活和更少的左侧杏仁核激活。
  • 这些个体还表现出右侧背外侧前额叶单脉冲TMS诱导的左侧杏仁核抑制更好,以及情绪冲突调节期间腹内侧前额叶/腹侧纹状体激活更大。
  • 重评相关激活不是治疗效果的显著调节因素。

临床怎么用

  • 基线fMRI情绪反应与调节任务中的背侧前额叶、左侧杏仁核及腹内侧前额叶/腹侧纹状体激活模式,可能有助于识别更可能从延长暴露治疗中获益的PTSD患者。
  • 右侧背外侧前额叶单脉冲TMS对左侧杏仁核的抑制程度可作为预测延长暴露疗效的候选功能指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Exposure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but many patients do not respond. Brain functions governing treatment outcome are not well characterized. The authors examined brain systems relevant to emotional reactivity and regulation, constructs that are thought to be central to PTSD and exposure therapy effects, to identify the functional traits of individuals most likely to benefit from treatment. METHOD: Individuals with PTSD underwent functional MRI (fMRI) while completing three tasks assessing emotional reactivity and regulation. Participants were then randomly assigned to immediate prolonged exposure treatment (N=36) or a waiting list condition (N=30). A random subset of the prolonged exposure group (N=17) underwent single-pulse transcranial magnetic stimulation (TMS) concurrent with fMRI to examine whether predictive activation patterns reflect causal influence within circuits. Linear mixed-effects modeling in line with the intent-to-treat principle was used to examine how baseline brain function moderated the effect of treatment on PTSD symptoms. RESULTS: At baseline, individuals with larger treatment-related symptom reductions (compared with the waiting list condition) demonstrated 1) greater dorsal prefrontal activation and 2) less left amygdala activation, both during emotion reactivity; 3) better inhibition of the left amygdala induced by single TMS pulses to the right dorsolateral prefrontal cortex; and 4) greater ventromedial prefrontal/ventral striatal activation during emotional conflict regulation. Reappraisal-related activation was not a significant moderator of the treatment effect. CONCLUSIONS: Capacity to benefit from prolonged exposure in PTSD is gated by the degree to which prefrontal resources are spontaneously engaged when superficially processing threat and adaptively mitigating emotional interference, but not when deliberately reducing negative emotionality.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD Psychotherapy Outcome Predicted by Brain Activation During Emotional Reactivity and Regulation. Am J Psychiatry. 2017. PMID: 28715908. doi:10.1176/appi.ajp.2017.16091072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。